Valuation Integra LifeSciences Holdings Corporation
Stocks
IART
US4579852082
Medical Equipment, Supplies & Distribution
|
Market Closed -
Nasdaq
21:00:00 24/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 16.69 USD | -0.30% |
|
-5.49% | +34.38% |
| 07-30 | BMO Cuts Price Target on Integra LifeSciences Holdings to $18 From $19, Keeps Market Perform Rating | MT |
| 07-29 | Integra LifeSciences Holdings Corporation, Q2 2026 Earnings Call, Jul 29, 2026 |
Company Valuation: Integra LifeSciences Holdings Corporation
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 5,674 | 4,683 | 3,405 | 1,750 | 967.4 | 1,298 | - | - |
| Change | - | -17.47% | -27.3% | -48.6% | -44.72% | 34.17% | - | - |
| Enterprise Value (EV) 1 | 6,707 | 5,670 | 4,605 | 3,285 | 2,563 | 2,787 | 2,583 | 2,363 |
| Change | - | -15.47% | -18.78% | -28.66% | -21.98% | 8.75% | -7.33% | -8.53% |
| P/E | 33.8x | 26x | 51.8x | -252x | -1.84x | 26.1x | 13.4x | 10.3x |
| PBR | 3.37x | 2.6x | 2.14x | 1.13x | 0.93x | 1.11x | 0.99x | 0.88x |
| PEG | - | 2.86x | -0.8x | 2x | -0x | -0x | 0.1x | 0.3x |
| Capitalization / Revenue | 3.68x | 3.01x | 2.21x | 1.09x | 0.59x | 0.78x | 0.75x | 0.73x |
| EV / Revenue | 4.35x | 3.64x | 2.99x | 2.04x | 1.57x | 1.66x | 1.49x | 1.32x |
| EV / EBITDA | 16.7x | 13.8x | 12.5x | 10.2x | 8.07x | 8.1x | 7.12x | 6.12x |
| EV / EBIT | 21.4x | 15.5x | 14x | 11.7x | 9.33x | 9.37x | 8.18x | 7.02x |
| EV / FCF | 25.4x | 25.5x | 63x | 132x | -82.5x | 12.2x | 18.7x | 15.3x |
| FCF Yield | 3.94% | 3.92% | 1.59% | 0.76% | -1.21% | 8.21% | 5.34% | 6.54% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 1.98 | 2.16 | 0.84 | -0.09 | -6.74 | 0.64 | 1.245 | 1.625 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 1,542 | 1,558 | 1,542 | 1,611 | 1,635 | 1,674 | 1,728 | 1,786 |
| EBITDA 1 | 400.7 | 411.3 | 369.7 | 322.2 | 317.5 | 344.3 | 363 | 385.9 |
| EBIT 1 | 314.1 | 366.6 | 329.1 | 281.1 | 274.8 | 297.6 | 315.9 | 336.3 |
| Net income 1 | 169.1 | 180.6 | 67.74 | -6.944 | -516.5 | 42.03 | 78.69 | 100.4 |
| Net Debt 1 | 1,033 | 986.7 | 1,200 | 1,535 | 1,596 | 1,489 | 1,285 | 1,064 |
| Reference price 2 | 66.99 | 56.07 | 43.55 | 22.68 | 12.42 | 16.69 | 16.69 | 16.69 |
| Nbr of stocks (in thousands) | 84,700 | 83,518 | 78,176 | 77,164 | 77,892 | 77,773 | - | - |
| Announcement Date | 23/02/22 | 22/02/23 | 28/02/24 | 25/02/25 | 26/02/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 26.16x | 1.67x | 8.11x | -.--% | 1.3B | |
| 33.46x | 4.49x | 17.25x | 2.2% | 202B | |
| 21.15x | 3.63x | 12.76x | 3.19% | 119B | |
| 17.42x | 0.2x | 12.74x | 0.75% | 60.69B | |
| 30.35x | 7.55x | 19.27x | 1.31% | 52.38B | |
| 37x | 3.53x | 12.12x | 2.04% | 52.3B | |
| 37.01x | 6.52x | 20.46x | -.--% | 34.85B | |
| 44.97x | 1.28x | 11.71x | 0.17% | 30.06B | |
| 41.17x | 7.21x | 25.89x | 0.26% | 24.85B | |
| 19.84x | 3.06x | 11.16x | 1.45% | 23.84B | |
| Average | 30.85x | 3.91x | 15.14x | 1.14% | 60.16B | |
| Weighted average by Cap. | 29.98x | 4.08x | 15.64x | 1.82% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- IART Stock
- Valuation Integra LifeSciences Holdings Corporation
Select your edition
All financial news and data tailored to specific country editions
